NIH Director Page NIH Health Information Page NIH Impact NIH Fact Sheets NIH Social Media and Outreach
EurekAlert! - National Institutes of Health  
LINKS

Resources

 

NIH Main

 

NIH Research News

 

Funded News

 
  For News & Research
  NIH Videos
  eColumn: NIH Research Matters
  NIH News in Health
  NIH Fact Sheets
 
  Additional Resources
  NIH Home Page
 

About NIH

  NIH Health Information
  Pub Med
  MedlinePlus
  Clinical trials.gov
  More News and Events Sources
  NIH News and Events, Special Interest
 
  RSS Feed RSS Feed
  Back to EurekAlert!
 

 


Department of Health and Human Services

News from the National Institutes of Health

Funded News


Key: Meeting M      Journal J      Funder F

Showing releases 3051-3075 out of 3465.

<< < 118 | 119 | 120 | 121 | 122 | 123 | 124 | 125 | 126 | 127 > >>

Public Release: 4-Nov-2013
Obesity Week
JAMA Surgery
Sexual function dramatically improves in women following bariatric surgery, Penn study finds
The first study to look extensively at sexual function in women who underwent bariatric surgery found that significant improvements in overall sexual function, most reproductive hormones and in psychological status were maintained over two years following surgery. Women reporting the poorest quality of sexual function prior to surgery saw the most dramatic improvements one year after surgery, on par with women who reported the highest quality of sexual function prior to surgery.
NIH/National Institute of Diabetes and Digestive and Kidney Diseases

Contact: Kim Menard
kim.menard@uphs.upenn.edu
215-662-6183
University of Pennsylvania School of Medicine

Public Release: 4-Nov-2013
JAMA Internal Medicine
Clinical trial indicates gabapentin is safe and effective for treating alcohol dependence
The generic drug gabapentin, which is already widely prescribed for epilepsy and some kinds of pain, appears to be safe and effective in the treatment of alcohol dependence. The finding comes from a 150-patient randomized, placebo-controlled, double blind clinical trial conducted by scientists at The Scripps Research Institute.
NIH/National Institute on Alcohol Abuse and Alcoholism

Contact: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute

Public Release: 4-Nov-2013
JAMA Internal Medicine
Women and African-Americans at higher risk of heart attack from atrial fibrillation
Doctors have known for years that atrial fibrillation, or irregular heartbeat, increases the risk for stroke, but now researchers at Wake Forest Baptist Medical Center have shown that it also increases the risk for heart attack. In fact, for women and African Americans, it more than doubles the risk.
NIH/National Institute of Neurological Disorders and Stroke

Contact: Marguerite Beck
marbeck@wakehealth.edu
336-716-2415
Wake Forest Baptist Medical Center

Public Release: 4-Nov-2013
Journal of Cell Biology
Learning and memory: How neurons activate PP1
A study in The Journal of Cell Biology describes how neurons activate the protein PP1, providing key insights into the biology of learning and memory.
National Institutes of Health

Contact: Rita Sullivan King
news@rupress.org
212-327-8603
Rockefeller University Press

Public Release: 4-Nov-2013
Journal of Studies on Alcohol and Drugs
Teens in child welfare system show higher drug abuse rate
Teenagers in the child welfare system are at higher-than-average risk of abusing marijuana, inhalants and other drugs, according to a study in the Nov. issue of the Journal of Studies on Alcohol and Drugs. However, the study also shows that parental involvement matters.
NIH/National Institute of Mental Health, Centers for Disease Control and Prevention

Contact: Debra Kain
ddkain@ucsd.edu
619-543-6202
Journal of Studies on Alcohol and Drugs

Public Release: 4-Nov-2013
Cancer Prevention Research
1 dose of HPV vaccine may be enough to prevent cervical cancer
Women vaccinated with one dose of a human papillomavirus (HPV) vaccine had antibodies against the viruses that remained stable in their blood for four years, suggesting that a single dose of vaccine may be sufficient to generate long-term immune responses and protection against new HPV infections, and ultimately cervical cancer, according to a study published in Cancer Prevention Research, a journal of the American Association for Cancer Research.
NIH/National Cancer Institute, Ministry of Health of Costa Rica

Contact: Jeremy Moore
jeremy.moore@aacr.org
215-446-7109
American Association for Cancer Research

Public Release: 4-Nov-2013
Pediatrics
Earlier onset of puberty in girls linked to obesity
New research in Pediatrics shows obesity is the largest predictor of earlier onset puberty in girls, which is affecting white girls much sooner than previously reported. Published online Nov. 4, the multi-institutional study strengthens a growing body of research documenting the earlier onset of puberty in girls of all races.
NIH/National Institute of Environmental Health Sciences, NIH/National Cancer Institute

Contact: Nick Miller
nicholas.miller@cchmc.org
513-803-6035
Cincinnati Children's Hospital Medical Center

Public Release: 3-Nov-2013
Nature Nanotechnology
Nanotube-based sensors can be implanted under the skin for a year
Research from MIT shows carbon nanotubes that detect nitric oxide can be implanted under the skin for more than a year.
Sanofi-Aventis, National Institutes of Health, NIH/National Cancer Institute, NIH/National Institute of Environmental Health Sciences, BYI Award, National Science Foundation

Contact: Sarah McDonnell
s_mcd@mit.edu
617-253-8923
Massachusetts Institute of Technology

Public Release: 3-Nov-2013
Nature
Penn researchers identify molecular link between gut microbes and intestinal health
Humans maintain a symbiotic relationship with the trillions of beneficial microbes that colonize their bodies. Inflammatory bowel disease is one of the best-studied diseases associated with alterations in the composition of beneficial bacterial populations. Researchers have identified that the enzyme HDAC3 -- important in epigenetics -- is a key mediator in maintaining proper intestinal integrity and function in the presence of friendly bacteria.
NIH/National Institute of Allergy and Infectious Disease, Crohns and Colitis Foundation of America

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine

Public Release: 1-Nov-2013
Proceedings of the National Academy of Sciences
ASU researchers discover new path to address genetic muscular diseases
For decades, scientists have searched for treatments for myopathies -- genetic muscular diseases such as muscular dystrophy and ALS, also called Lou Gehrig's disease. Now, an interdisciplinary team of researchers from Arizona State and Stanford Universities, and the University of Arizona, has discovered a new avenue to search for treatment possibilities.
Muscular Dystrophy Association, Glenn Foundation for Medical Research, National Institutes of Health Director's Pioneer Award, Department of Veterans Affairs, American Heart Association

Contact: Sandra Leander
sandra.leander@asu.edu
480-965-9865
Arizona State University

Public Release: 1-Nov-2013
American Journal of Psychiatry
Bipolar and pregnant
New research offers one of the first in-depth views of how metabolism changes during pregnancy reduce the effect of a commonly used drug to treat bipolar disorder. The blood level of the drug decreased during pregnancy, resulting in worsening symptoms. The new findings can help physicians prevent bipolar manic and depressive episodes in their pregnant patients, which are risky for the health of the mother and her unborn child.
NIH/National Institute of Mental Health

Contact: Marla Paul
marla-paul@northwestern.edu
312-503-8928
Northwestern University

Public Release: 1-Nov-2013
MU receives $1.1 million training grant to increase diversity in biomedical sciences
Since 2003, University of Missouri faculty have been working to increase diversity in 30 biomedical sciences departments and programs by recruiting minority students into the MU Post-baccalaureate Research Education Program. Now, a $1.1 million training grant from the National Institutes of Health will allow the program to continue for another four years.
National Institutes of Health

Contact: Melody Kroll
KrollMM@missouri.edu
573-884-4144
University of Missouri-Columbia

Public Release: 1-Nov-2013
Journal of the American Heart Association
Brushing your teeth could prevent heart disease
Taking care of your gums by brushing, flossing, and regular dental visits could help hold heart disease at bay. Researchers at Columbia University's Mailman School of Public Health have shown for the first time that as gum health improves, progression of atherosclerosis slows to a clinically significant degree. Findings appear online in the Journal of the American Heart Association.
National Institutes of Health, Institut National de la Santé et de la Recherche Medicale, Mayo Chair Endowment

Contact: Timothy S. Paul
tp2111@columbia.edu
212-305-2676
Columbia University's Mailman School of Public Health

Public Release: 1-Nov-2013
Proceedings of the National Academy of Sciences
A new model for organ repair
Harvard Stem Cell Institute researchers have a new model for how the kidney repairs itself, a model that adds to a growing body of evidence that mature cells are far more plastic than had previously been imagined.
National Institutes of Health

Contact: B. D. Colen
bd_colen@harvard.edu
617-413-1224
Harvard University

Public Release: 1-Nov-2013
Proceedings of the National Academy of Sciences
Pitt treats gum disease by bringing needed immune cells to inflamed tissue
The red, swollen and painful gums and bone destruction of periodontal disease could be treated by beckoning the right kind of immune system cells to the inflamed tissues, according to a new animal study conducted by researchers at the University of Pittsburgh. Their findings, published in the online version of the Proceedings of the National Academy of Sciences, offer a new therapeutic paradigm for a condition that afflicts 78 million people in the US alone.
National Institutes of Health, Wallace H. Coulter Foundation, Camille and Henry Dreyfus Foundation, Arnold and Mabel Beckman Foundation, Commonwealth of Pennsylvania

Contact: Anita Srikameswaran
SrikamAV@upmc.edu
412-720-2058
University of Pittsburgh Schools of the Health Sciences

Public Release: 1-Nov-2013
Neuron
Neuroscientists determine how treatment for anxiety disorders silences fear neurons
In a study published in Neuron, Tufts neuroscientists report that exposure therapy, a common treatment for anxiety disorders, remodels an inhibitory junction in the mouse brain. The findings improve the understanding of how exposure therapy suppresses fear responses and may aid in the development of more effective treatments for anxiety disorders.
National Institutes of Health

Contact: Siobhan Gallagher
siobhan.gallagher@tufts.edu
617-636-6586
Tufts University, Health Sciences Campus

Public Release: 1-Nov-2013
Brain, Behavior and Immunity
Children of lower socioeconomic status grow up more susceptible to catching colds, Carnegie Mellon researchers find
Researchers at Carnegie Mellon University have found an association between lower socioeconomic status during childhood and adolescence and the length of telomeres, protective cap-like protein complexes at the end of chromosomes, that ultimately affects the susceptibility to colds in middle-aged adults. Published in Brain, Behavior and Immunity, the study showed that children and teens with parents of lower socioeconomic status have shorter telomeres as adults.
NIH/National Institute of Allergy and Infectious Diseases, NIH/National Center for Complementary and Alternative Medicine

Contact: Shilo Rea
shilo@cmu.edu
412-268-6094
Carnegie Mellon University

Public Release: 1-Nov-2013
Pediatrics
Home visits lessen emergency care for infants
Home visits from a nurse are a proven but expensive way to help newborns get a good start in life. New research from Duke University suggests that less costly home visiting programs can reach more families and still produce significant health care improvements. Infants in the study had 50 percent fewer emergency care episodes than other babies in the first year of life.
NIH/National Institute on Drug Abuse, The Duke Endowment, Pew Center on the States

Contact: Alison Jones
Alison.jones@duke.edu
919-681-8504
Duke University

Public Release: 1-Nov-2013
Journal of Clinical Investigation
Dysfunctional chemokine receptor promotes candidiasis
In this issue of the Journal of Clinical Investigation, Michail Lionakis and colleagues at the National Institute of Allergy and Infectious Diseases demonstrated that the chemokine receptor CX3CR1 is required for the interaction of C. albicans and macrophages in the kidney.
NIH/Division of Intramural Research, NIH/National Institute of Allergy and Infectious Diseases, NIH/Transition Program in Clinical Research

Contact: Corinne Williams
press_releases@the-jci.org
Journal of Clinical Investigation

Public Release: 1-Nov-2013
Journal of Clinical Investigation
JCI early table of contents for Nov. 1, 2013
This release contains summaries, links to PDFs, and contact information for the following newsworthy papers to be published online, Nov. 1, 2013 in the JCI: "Liver tropism is key for B cell deletion immunotherapy," "Dysfunctional chemokine receptor promotes candidiasis," "Retinoblastoma protein prevents enteric nervous system defects and intestinal pseudo-obstruction," "Transmembrane protein ESDN promotes endothelial VEGF signaling and regulates angiogenesis," "Apelin is a positive regulator of ACE2 in failing hearts," and more.
National Institutes of Health, Fonds de la Recherche du Québec-Santé, Knights Templar Eye Foundation, Children's Discovery Institute

Contact: Corinne Williams
press_releases@the-jci.org
Journal of Clinical Investigation

Public Release: 31-Oct-2013
Science
Scientists capture most detailed picture yet of key AIDS protein
Collaborating scientists at the Scripps Research Institute and Weill Cornell Medical College have determined the first atomic-level structure of the tripartite HIV envelope protein -- long considered one of the most difficult targets in structural biology and of great value for medical science.
NIH/National Institute of General Medical Sciences, International AIDS Vaccine Initiative Neutralizing Antibody Consortium

Contact: Sarah Smith
sas2072@med.cornell.edu
646-317-7401
Weill Cornell Medical College

Public Release: 31-Oct-2013
Frontiers in Neurology
Microbleeds important to consider in brain-related treatments, UCI neurologist says
As growing numbers of America's baby boomers reach retirement, neuroscientists are expanding their efforts to understand and treat one of the leading health issues affecting this population: age-related neurological deterioration, including stroke and dementia.
National Institutes of Health

Contact: Tom Vasich
tmvasich@uci.edu
949-824-6455
University of California - Irvine

Public Release: 31-Oct-2013
Frontiers in Psychology
NYU study on incarcerated youth shows potential to lower anti-social behavior and recidivism
It is the first study to show that mindfulness training can be used in combination with cognitive behavioral therapy to protect attentional functioning in high-risk incarcerated youth.
NIH/National Institute on Drug Abuse

Contact: Christopher James
christopher.james@nyu.edu
212-998-6876
New York University

Public Release: 31-Oct-2013
Akron researcher awarded NIH grant for advancing 3-D tumor models for anticancer drug testing
University of Akron assistant professor of biomedical engineering Hossein Tavana was awarded $511,000 from the National Institutes of Health to support his efforts to improve chemotherapeutic drug testing and effectiveness. Tavana has developed a novel method of generating 3-D cultures of cancer cells that better mimic tumors in the body. Tavana calls this the next step toward personalized medicine by which doctors could extract and test patients' cancer cells in vitro to determine the most effective treatment in vivo.
National Institutes of Health

Contact: Denise Henry
henryd@uakron.edu
330-972-6477
University of Akron

Public Release: 31-Oct-2013
PLOS Computational Biology
Automated system promises precise control of medically induced coma
Putting patients with severe head injuries or persistent seizures into a medically induced coma currently requires that a nurse or other health professional constantly monitor the patient's brain activity and manually adjust drug infusion to maintain a deep state of anesthesia. Now a computer-controlled system developed by Massachusetts General Hospital investigators promises to automate the process, making it more precise and efficient and opening the door to more advanced control of anesthesia.
National Institutes of Health

Contact: Sue McGreevey
smcgreevey@partners.org
617-724-2764
Massachusetts General Hospital

Showing releases 3051-3075 out of 3465.

<< < 118 | 119 | 120 | 121 | 122 | 123 | 124 | 125 | 126 | 127 > >>

     
   

HOME    DISCLAIMER    PRIVACY POLICY    CONTACT US
Copyright ©2014 by AAAS, the science society.